AltPep Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
AltPep is a Seattle-based biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, focusing on toxic soluble oligomers as a key early trigger. Building on decades of work by the Daggett Research Group, the company derives its approach from a newly described protein structure, alpha-sheet, that underpins its strategy. Its lead program aims to identify Alzheimer's disease before symptoms manifest and to neutralize the toxic oligomers associated with the condition. The company operates as a privately held firm with a small team. In 2025, AltPep presented preclinical data on SOBIN-AD at AAIC 2025 and CTAD 2025, illustrating advances in its lead program.